NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 107043 | Null | 0.0267520285931239 | 0.60492075 |
NSC 120925 | Null | 0.0267520285931239 | 0.23774308 |
NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0267520285931239 | 0.21392761 |
NSC 295272 | Null | 0.0267520285931239 | 0.24270984 |
NSC 330507 | Tanespimycin | 0.0267520285931239 | 0.27824831 |
NSC 350629 | 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester | 0.0267520285931239 | 0.371875 |
NSC 357777 | Null | 0.0267520285931239 | 0.23829844 |
NSC 623723 | Null | 0.0267520285931239 | 0.39675033 |
NSC 624191 | Null | 0.0267520285931239 | 0.46712945 |
NSC 625624 | 7,12-Epidioxybenz[a]anthracene, 7,12-dihydro-7-methyl- | 0.0267520285931239 | 0.455392 |